First Page | Document Content | |
---|---|---|
Date: 2014-06-30 21:58:23Pharmaceutical industry Pharmaceutical sciences Research Drug development Clinical trial William K. Oh Richmond Pharmacology Ltd Medicine Pharmacology Drug discovery | Microsoft Word - IDSC_Pubs_Listing_5[removed]docAdd to Reading ListSource URL: www.cancer.govDownload Document from Source WebsiteFile Size: 12,69 KBShare Document on Facebook |
· Prostate Cancer · Is Docetaxel Chemotherapy a New Standard of Care for Metastatic Hormone-Sensitive Prostate Cancer? Bobby C. Liaw, MD, and William K. Oh, MDDocID: 1m55m - View Document | |
BVKC - SBCC Belgian Society for Clinical Chemistry Dear visitor This is one of the presentations of the 2007 symposium ofDocID: 18DOw - View Document | |
12-14 JULY 2015 SOFITEL SYDNEY WENTWORTH ANZUP ANNUAL SCIENTIFIC MEETING Redefining Personalised Medicine #ANZUP15DocID: 18gyj - View Document | |
New Blood and Urine Tests to Improve Detection of Aggressive Prostate Cancer: Progress from the NCI Early Detection Research Network Martin G. Sanda, MD Professor and Chairman of Urology Emory University School of MediciDocID: 17Tom - View Document | |
PDF DocumentDocID: 17rRN - View Document |